In our study cohort, plasma IL6, CRP, and neopterin concentrations at admission were significantly higher in patients developing severe COVID‐19 than in subjects with moderate disease, as described previously [12] (Supporting information Figure S3A). The gene discussed is IL6; the disease is COVID-19.